Assessing post-COVID-19 respiratory dynamics: a comprehensive analysis of pulmonary function, bronchial hyperresponsiveness and bronchodilator response.

ERJ Open Res · 2024 · PMC11456966 · PMID 39377091

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.0820

boldest claim

The sentences

approaching significancep=0.050actually significant

COPD showed distinctions in comorbidities, with Groups 1, 2, 3 and 4 at 15%, 14%, 8% and 0%, respectively, approaching significance (p=0.050).

also in 483 other papers

showed a trendp=0.082so close (0.05 < p ≤ 0.1)

For patients in Groups 3 and 4, the PC20 showed a trend towards increased AHR (4.8±3.4 mg·mL −1 and 3.5±3.0 mg·mL −1 in Group 3 and Group 4, respectively) (p=0.082).

also in 11,799 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.